• Something wrong with this record ?

MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function

R. Brauer, J. Tureckova, I. Kanchev, M. Khoylou, J. Skarda, J. Prochazka, F. Spoutil, IM. Beck, O. Zbodakova, P. Kasparek, V. Korinek, K. Chalupsky, T. Karhu, KH. Herzig, M. Hajduch, M. Gregor, R. Sedlacek,

. 2016 ; 9 (4) : 974-85. [pub] 20151111

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc18017384

Matrix metalloproteinases (MMPs) are potential biomarkers for disease activity in inflammatory bowel disease (IBD). However, clinical trials targeting MMPs have not succeeded, likely due to poor understanding of the biological functions of individual MMPs. Here, we explore the role of MMP-19 in IBD pathology. Using a DSS-induced model of colitis, we show evidence for increased susceptibility of Mmp-19-deficient (Mmp-19(-/-)) mice to colitis. Absence of MMP-19 leads to significant disease progression, with reduced survival rates, severe tissue destruction, and elevated levels of pro-inflammatory modulators in the colon and plasma, and failure to resolve inflammation. There was a striking delay in neutrophil infiltration into the colon of Mmp-19(-/-) mice during the acute colitis, leading to persistent inflammation and poor recovery; this was rescued by reconstitution of irradiated Mmp-19(-/-) mice with wild-type bone marrow. Additionally, Mmp-19-deficient macrophages exhibited decreased migration in vivo and in vitro and the mucosal barrier appeared compromised. Finally, chemokine fractalkine (CX3CL1) was identified as a novel substrate of MMP-19, suggesting a link between insufficient processing of CX3CL1 and cell recruitment in the Mmp-19(-/-) mice. MMP-19 proves to be a critical factor in balanced host response to colonic pathogens, and for orchestrating appropriate innate immune response in colitis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017384
003      
CZ-PrNML
005      
20180524110332.0
007      
ta
008      
180515s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/mi.2015.117 $2 doi
035    __
$a (PubMed)26555704
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Brauer, R $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic. Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, USA.
245    10
$a MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function / $c R. Brauer, J. Tureckova, I. Kanchev, M. Khoylou, J. Skarda, J. Prochazka, F. Spoutil, IM. Beck, O. Zbodakova, P. Kasparek, V. Korinek, K. Chalupsky, T. Karhu, KH. Herzig, M. Hajduch, M. Gregor, R. Sedlacek,
520    9_
$a Matrix metalloproteinases (MMPs) are potential biomarkers for disease activity in inflammatory bowel disease (IBD). However, clinical trials targeting MMPs have not succeeded, likely due to poor understanding of the biological functions of individual MMPs. Here, we explore the role of MMP-19 in IBD pathology. Using a DSS-induced model of colitis, we show evidence for increased susceptibility of Mmp-19-deficient (Mmp-19(-/-)) mice to colitis. Absence of MMP-19 leads to significant disease progression, with reduced survival rates, severe tissue destruction, and elevated levels of pro-inflammatory modulators in the colon and plasma, and failure to resolve inflammation. There was a striking delay in neutrophil infiltration into the colon of Mmp-19(-/-) mice during the acute colitis, leading to persistent inflammation and poor recovery; this was rescued by reconstitution of irradiated Mmp-19(-/-) mice with wild-type bone marrow. Additionally, Mmp-19-deficient macrophages exhibited decreased migration in vivo and in vitro and the mucosal barrier appeared compromised. Finally, chemokine fractalkine (CX3CL1) was identified as a novel substrate of MMP-19, suggesting a link between insufficient processing of CX3CL1 and cell recruitment in the Mmp-19(-/-) mice. MMP-19 proves to be a critical factor in balanced host response to colonic pathogens, and for orchestrating appropriate innate immune response in colitis.
650    _2
$a zvířata $7 D000818
650    _2
$a pohyb buněk $7 D002465
650    _2
$a kultivované buňky $7 D002478
650    _2
$a chemokin CX3CL1 $x metabolismus $7 D054428
650    _2
$a kolitida $x chemicky indukované $x imunologie $7 D003092
650    _2
$a kolon $x imunologie $7 D003106
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a síran dextranu $7 D016264
650    _2
$a progrese nemoci $7 D018450
650    _2
$a lidé $7 D006801
650    _2
$a přirozená imunita $7 D007113
650    _2
$a mediátory zánětu $x metabolismus $7 D018836
650    _2
$a idiopatické střevní záněty $x imunologie $7 D015212
650    _2
$a střevní sliznice $x imunologie $x patologie $7 D007413
650    _2
$a makrofágy $x imunologie $7 D008264
650    _2
$a metaloproteinasy secernované do matrix $x genetika $x metabolismus $7 D053505
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a infiltrace neutrofily $x genetika $7 D020556
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Tureckova, J $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
700    1_
$a Kanchev, I $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
700    1_
$a Khoylou, M $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
700    1_
$a Skarda, J $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
700    1_
$a Prochazka, J $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
700    1_
$a Spoutil, F $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
700    1_
$a Beck, I M $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
700    1_
$a Zbodakova, O $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
700    1_
$a Kasparek, P $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic. Faculty of Sciences, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Korinek, V $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
700    1_
$a Chalupsky, K $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
700    1_
$a Karhu, T $u Institute of Biomedicine and Biocenter of Oulu, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
700    1_
$a Herzig, K-H $u Institute of Biomedicine and Biocenter of Oulu, Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
700    1_
$a Hajduch, M $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
700    1_
$a Gregor, M $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic. Institute of Molecular Genetics of the ASCR, Laboratory of Integrative Biology, Prague, Czech Republic.
700    1_
$a Sedlacek, R $u Institute of Molecular Genetics of the ASCR, Laboratory of Transgenic Models of Diseases, Prague, Czech Republic.
773    0_
$w MED00195155 $t Mucosal immunology $x 1935-3456 $g Roč. 9, č. 4 (2016), s. 974-85
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26555704 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180524110518 $b ABA008
999    __
$a ok $b bmc $g 1301008 $s 1014224
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 9 $c 4 $d 974-85 $e 20151111 $i 1935-3456 $m Mucosal immunology $n Mucosal Immunol $x MED00195155
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Archiving options